fda bpc-157 warning letter unapproved new drug issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA's Overreach on Compounded Peptides
FDA's Overreach on Compounded Peptides A closer look at the unapproved peptide injections promoted by influencers and celebrities FDA warning letters target marketers of unapproved weight loss drugs RAPS US signals crackdown on compounded weight loss drugs; Hims shares tumble Reuters The Trend of Unproven Peptides Is Spreading Through Influencers and RFK Jr. Allies
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




